ConductScience.org, home

Paper20554145

Molecular imaging of cancer: MR spectroscopy and beyond.

Pinker K and 4 others. Eur J Radiol, 2012. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Molecular imaging of cancer: MR spectroscopy and beyond. Papers, record 20554145. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20554145

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular imaging of cancer: MR spectroscopy and beyond.
PubMed
Journal
Eur J Radiol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2015-11-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinker KK
2Stadlbauer AA
3Bogner WW
4Gruber SS
5Helbich THT H

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Magnetic Resonance SpectroscopyMajor topic
Molecular ImagingMajor topic
NeoplasmsMajor topic
Contrast Media
Diffusion Magnetic Resonance Imaging
Humans
Sensitivity and Specificity
Sodium

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
41966642MR-based techniques for imaging prostate cancer metabolism: current status and future perspectives.Abdom Radiol (NY)2026https://conductscience.org/library/papers/41966642PubMed
34374098Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.Med Phys2022https://conductscience.org/library/papers/34374098PubMed
33194769Manganese-Based Targeted Nanoparticles for Postoperative Gastric Cancer Monitoring via Magnetic Resonance Imaging.Front Oncol2020https://conductscience.org/library/papers/33194769PubMed
32899427Radioresistance in Glioblastoma and the Development of Radiosensitizers.Cancers (Basel)2020https://conductscience.org/library/papers/32899427PubMed
32751723Clinical Feasibility of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging with Computed Diffusion-Weighted Imaging Technique in Breast Cancer Patients.Diagnostics (Basel)2020https://conductscience.org/library/papers/32751723PubMed
29393071MRI-only treatment planning: benefits and challenges.Phys Med Biol2018https://conductscience.org/library/papers/29393071PubMed
29229179Clinical role of breast MRI now and going forward.Clin Radiol2018https://conductscience.org/library/papers/29229179PubMed
27805423The potential of multiparametric MRI of the breast.Br J Radiol2017https://conductscience.org/library/papers/27805423PubMed
27399100Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer.Medicine (Baltimore)2016https://conductscience.org/library/papers/27399100PubMed
27372708Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients.Radiol Med2016https://conductscience.org/library/papers/27372708PubMed
27364727[Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].Radiologe2016https://conductscience.org/library/papers/27364727PubMed
26712681Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?Diagn Interv Radiol2016https://conductscience.org/library/papers/26712681PubMed
26687855The Potential of Metabolic Imaging.Semin Nucl Med2016https://conductscience.org/library/papers/26687855PubMed
26589201[Multiparametric imaging with simultaneous MRI/PET: Methodological aspects and possible clinical applications].Z Rheumatol2015https://conductscience.org/library/papers/26589201PubMed
26413543MRI for Crohn's Disease: Present and Future.Biomed Res Int2015https://conductscience.org/library/papers/26413543PubMed
25608557The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis.Cancer Imaging2014https://conductscience.org/library/papers/25608557PubMed
24557495[Molecular breast imaging. An update].Radiologe2014https://conductscience.org/library/papers/24557495PubMed
23970895SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows.Int J Biomed Imaging2013https://conductscience.org/library/papers/23970895PubMed
23949435[Multiparametric imaging with simultaneous MR/PET. Methodological aspects and possible clinical applications].Radiologe2013https://conductscience.org/library/papers/23949435PubMed
23740024Preliminary observations and clinical value of lipid peak in high-grade uterine sarcomas using in vivo proton MR spectroscopy.Eur Radiol2013https://conductscience.org/library/papers/23740024PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20554145

GET https://conductscience.org/api/papers/v1/20554145/cited_by?page=2